Top drug distributors in talks to settle opioid litigation for $18 billion, report says

Health, Fitness & Food

State and local officials are reportedly in talks with three major drug distributors on a potential $18 billion settlement of litigation that blames them for helping to fuel the U.S. opioid epidemic.

The potential settlement, according to the Wall Street Journal, would require McKesson Corp., AmerisourceBergen Corp. and Cardinal Health to collectively pay the $18 billion over 18 years. Drugmaker Johnson & Johnson is also involved in the discussions to pay extra money, the WSJ reported, citing people familiar with the discussions. 

This is breaking news. Please check back for updates.

Products You May Like

Articles You May Like

New York to investigate potential coronavirus cluster from graduation after Florida traveler tests positive
Long-term exposure to fine atmospheric particles can lead to increased mortality rates among the elderly
Texas reports record number of new coronavirus cases, extends ban on elective surgeries
Rutgers researchers describe characteristics, treatments and outcomes of MIS-C
Study: Even moderate exercise during pregnancy boosts benefits of breastmilk for babies

Leave a Reply

Your email address will not be published. Required fields are marked *